The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters : Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area
BACKGROUND: Iodine supplementation during pregnancy in areas with mild-to-moderate iodine deficiency is still debated.
METHODS: A single-center, randomized, single-blind and placebo-controlled (3:2) trial was conducted. We enrolled 90 women before 12 weeks of gestation. From enrollment up until 8 weeks after delivery, 52 women were given an iodine supplement (225 ug/day, potassium iodide tablets) and 38 were given placebo. At recruitment (T0), in the second (T1) and third trimesters (T2), and 8 weeks after delivery (T3), we measured participants' urinary iodine-to-creatinine ratio (UI/Creat), thyroid function parameters (thyroglobulin (Tg), TSH, FT3, and FT4), and thyroid volume (TV). The newborns' urinary iodine concentrations were evaluated in 16 cases.
RESULTS: Median UI/Creat at recruitment was 53.3 ug/g. UI/Creat was significantly higher in supplemented women at T1 and T2. Tg levels were lower at T1 and T2 in women with UI/Creat ≥ 150 ug/g, and in the Iodine group at T2 (p = 0.02). There was a negative correlation between Tg and UI/Creat throughout the study (p = 0.03, r = -0.1268). A lower TSH level was found in the Iodine group at T3 (p = 0.001). TV increased by +Δ7.43% in the Iodine group, and by +Δ11.17% in the Placebo group. No differences were found between the newborns' TSH levels on screening the two groups.
CONCLUSION: Tg proved a good parameter for measuring iodine intake in our placebo-controlled series. Iodine supplementation did not prove harmful to pregnancy in areas of mild-to-moderate iodine deficiency, with no appreciable harmful effect on thyroid function.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Nutrients - 11(2019), 11 vom: 04. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Censi, Simona [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.05.2020 Date Revised 08.05.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/nu11112639 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM302940227 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM302940227 | ||
003 | DE-627 | ||
005 | 20231225111759.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/nu11112639 |2 doi | |
028 | 5 | 2 | |a pubmed24n1009.xml |
035 | |a (DE-627)NLM302940227 | ||
035 | |a (NLM)31689890 | ||
035 | |a (PII)E2639 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Censi, Simona |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters |b Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.05.2020 | ||
500 | |a Date Revised 08.05.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Iodine supplementation during pregnancy in areas with mild-to-moderate iodine deficiency is still debated | ||
520 | |a METHODS: A single-center, randomized, single-blind and placebo-controlled (3:2) trial was conducted. We enrolled 90 women before 12 weeks of gestation. From enrollment up until 8 weeks after delivery, 52 women were given an iodine supplement (225 ug/day, potassium iodide tablets) and 38 were given placebo. At recruitment (T0), in the second (T1) and third trimesters (T2), and 8 weeks after delivery (T3), we measured participants' urinary iodine-to-creatinine ratio (UI/Creat), thyroid function parameters (thyroglobulin (Tg), TSH, FT3, and FT4), and thyroid volume (TV). The newborns' urinary iodine concentrations were evaluated in 16 cases | ||
520 | |a RESULTS: Median UI/Creat at recruitment was 53.3 ug/g. UI/Creat was significantly higher in supplemented women at T1 and T2. Tg levels were lower at T1 and T2 in women with UI/Creat ≥ 150 ug/g, and in the Iodine group at T2 (p = 0.02). There was a negative correlation between Tg and UI/Creat throughout the study (p = 0.03, r = -0.1268). A lower TSH level was found in the Iodine group at T3 (p = 0.001). TV increased by +Δ7.43% in the Iodine group, and by +Δ11.17% in the Placebo group. No differences were found between the newborns' TSH levels on screening the two groups | ||
520 | |a CONCLUSION: Tg proved a good parameter for measuring iodine intake in our placebo-controlled series. Iodine supplementation did not prove harmful to pregnancy in areas of mild-to-moderate iodine deficiency, with no appreciable harmful effect on thyroid function | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a iodine | |
650 | 4 | |a mild-to-moderate iodine deficiency | |
650 | 4 | |a pregnancy | |
650 | 4 | |a randomized and placebo-controlled trial | |
650 | 7 | |a Trace Elements |2 NLM | |
650 | 7 | |a Thyroglobulin |2 NLM | |
650 | 7 | |a 9010-34-8 |2 NLM | |
650 | 7 | |a Iodine |2 NLM | |
650 | 7 | |a 9679TC07X4 |2 NLM | |
650 | 7 | |a Thyroxine |2 NLM | |
650 | 7 | |a Q51BO43MG4 |2 NLM | |
700 | 1 | |a Watutantrige-Fernando, Sara |e verfasserin |4 aut | |
700 | 1 | |a Groccia, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Manso, Jacopo |e verfasserin |4 aut | |
700 | 1 | |a Plebani, Mario |e verfasserin |4 aut | |
700 | 1 | |a Faggian, Diego |e verfasserin |4 aut | |
700 | 1 | |a Mion, Monica Maria |e verfasserin |4 aut | |
700 | 1 | |a Venturini, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Andrisani, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Casaro, Anna |e verfasserin |4 aut | |
700 | 1 | |a Vita, Pietro |e verfasserin |4 aut | |
700 | 1 | |a Avogadro, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Camilot, Marta |e verfasserin |4 aut | |
700 | 1 | |a Scaroni, Carla |e verfasserin |4 aut | |
700 | 1 | |a Bertazza, Loris |e verfasserin |4 aut | |
700 | 1 | |a Barollo, Susi |e verfasserin |4 aut | |
700 | 1 | |a Mian, Caterina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nutrients |d 2009 |g 11(2019), 11 vom: 04. Nov. |w (DE-627)NLM206140738 |x 2072-6643 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2019 |g number:11 |g day:04 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/nu11112639 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2019 |e 11 |b 04 |c 11 |